SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech failure, 2002
An SI Board Since January 2002
Posts SubjectMarks Bans
130 20 0
Emcee:  Miljenko Zuanic Type:  Unmoderated
Introduction Compact
This is not discussion tread. It is designee only to record major failure by bios in 2002.

I will update for past two weeks, but for now it will start with Miravant.

Miljenko
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
130QLT not the only ones with egg on their face. I have to admit that I thought XNnigel bates-5/13/2003
129When I see these phase III failures I always want to ask: "How could they aIcebrg-5/13/2003
128siliconinvestor.com >> However, mdr is a kiss of death in more than one sscaram(o)uche-5/12/2003
127QLT discontinues tariquidar phase III non-small cell lung cancer trials followinIcebrg-5/12/2003
126Yes, why not. Subject 53705Miljenko Zuanic-2/18/2003
125Time for a 2003 thread ? FREMONT, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Sannigel bates-2/18/2003
124>>BOTHELL, Wash.--(BUSINESS WIRE)--Dec. 19, 2002-- ICOS Corporation ("tuck-12/19/2002
123Titan Announces Results of CeaVac Clinical Study in Colorectal Cancer Wednesday Icebrg-12/11/2002
122Press Release Source: Transkaryotic Therapies, Inc. TKT Reports Preliminary ReMiljenko Zuanic-11/27/2002
121Nrgn: Message 18223340mopgcw-11/12/2002
120Chiron Announces Discontinuation of SILCAAT and HBV-MF59 Trials And PA-1806 Progkeokalani'nui-10/23/2002
119Seattle Genetics Provides Update On SGN-14 BOTHELL, Wash., Oct 8, 2002 (BUSINESIcebrg-10/8/2002
118JTT-501 bites the dust. Japan Tobacco To Terminate Diabetes Drug Development Mkeokalani'nui-10/7/2002
117Transkaryotic Shares Plunge By DENISE GELLENE [LA]TIMES STAFF WRITER October 3sim1-10/3/2002
116Press Release Source: Transkaryotic Therapies, Inc. TKT Provides Regulatory anMiljenko Zuanic-10/2/2002
115MOUNTAIN VIEW, Calif., Sept. 27 /PRNewswire-FirstCall/ -- IntraBiotics Pharmaceunigel bates-9/28/2002
114Plain old crap, IMO. Based on your input, re inflammation.Miljenko Zuanic-9/24/2002
113This is really infuriating. It's always been confusing.... did they knoscaram(o)uche-9/24/2002
112What a mediocre plan? <<Genmab will continue with its Phase IIb developmenMiljenko Zuanic-9/24/2002
111Press Release Source: Cortech, Inc. Announcement of the Suspension of ClinicalMiljenko Zuanic-9/24/2002
110INCR's deligoparin (ultra low molecular weight heparin) fails and is abandonRCMac-9/17/2002
109BS about remission significance, without number for primary end-point. Maybe theMiljenko Zuanic-9/16/2002
108>> Not as much as failure as it is *BS* report! << Yeah. Seems likscaram(o)uche-9/16/2002
107The only BS I could see is no statement that 57 days was a previously determinedkeokalani'nui-9/16/2002
106This is BAD for MLNM. Not as much as failure as it is *BS* report! Press ReleaMiljenko Zuanic-9/16/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News